Loading
HI
Hemobiotech Inc Stock: price and insider trades · United States
No insider purchase over the last 90 days. The latest, by Baron Robert, was filed 21 Mar 2006.
Hemobiotech Inc: what insiders have been doing
Hemobiotech Inc is a listed company. Filings by its managers are published through SEC (Form 4). Nothing new has been filed by managers of Hemobiotech Inc in twelve months, the latest record being from 9 March 2009.
Looking back to 2006, when coverage begins, insiders filed 3 purchases and 1 sale.
These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.
Insider Decl.
11
Thresholds
n/a
Buy Volume
€15,518
3 ops. · all time
Sell Volume
€884,017
1 ops. · all time
Last declaration on 9 March 2009
Declarations11 total
65,000 sharesCommon Stock, par value $0.001 per shareSEC:0001140361-09-006354:0
651,668 shares@ US$0.20Common Stock, par value $0.001 per shareSEC:0001140361-08-024228:0
130,334 shares@ US$1.00Common Stock, par value $0.001 per shareSEC:0001140361-08-024228:1
1,000,000 shares@ US$1.17Common Stock, $.001 par valueSEC:0001140361-07-005860:0
17,647 shares@ US$1.06Common StockSEC:0001301348-06-000029:0
1,850 shares@ US$1.85Common Stock, par value $.001 per shareSEC:0000911420-06-000218:0
Canonical exit: 15 Jun 2006 (T+90)
3,150 shares@ US$1.75Common Stock, par value $.001 per shareSEC:0000911420-06-000218:1
Canonical exit: 18 Jun 2006 (T+90)
362,500 shares0Common StockSEC:0001144204-06-010012:0
5,000 shares@ US$1.95Common Stock, par value $.001 per shareSEC:0000911420-06-000149:0
Canonical exit: 24 May 2006 (T+90)
100,000 shares0Common StockSEC:0001144204-06-006655:0
363,000 shares0Common StockSEC:0001144204-06-006654:0
11 of 11 declarations
About Hemobiotech Inc
Hemobiotech Inc is a company listed on the XNAS market, specializing in the development of biopharmaceutical solutions. It focuses on innovation in the field of blood treatments.
